Conflicting Data on Invokana and Kidney Injuries: Manufacturer’s Study Shows “Improved Renal Outcomes,” Independent Research Indicates Otherwise

by KJ McElrath | Nov 8, 2017 | Invokana |

Patients with Type 2 diabetes who take the prescription medication Invokana (canagliflozin) either...

Johnson & Johnson Moves Ahead in Seeking Approval For Expanded Use of Invokana

by KJ McElrath | Oct 12, 2017 | Invokana |

Despite the demonstrated links between lower limb amputations, kidney failure, osteoporosis and...

Despite Onslaught of Injury Lawsuits, Janssen Cuts Deal with European Distributor for Invokana

by KJ McElrath | Sep 20, 2017 | Invokana |

While injury lawsuits over the diabetic medication Invokana (canagliflozin) continue to pile up...

The Proof Is In: Invokana Puts Diabetic Patients at Greater Risk for Amputation

by KJ McElrath | May 18, 2017 | Invokana |

Last year, the European Medicines Agency (EMA) started an investigation into the possibility that...

Invokana Maker Turned Health Care Consumers into Guinea Pigs

by KJ McElrath | Apr 1, 2017 | Invokana |

If you were fully informed about the potential side effects of a medication, would you still...

Popular Diabetes Medication Linked to Kidney Failure

by Mike Papantonio | Mar 3, 2017 | Invokana |

Via America’s Lawyer: According to latest data from the Centers for Disease Control, more...